Stay updated with breaking news from Christopher Oconnor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA CRDAC convened on Septemeber 13 to discuss the sNDA for patisiran as a treatment for ATTR-CM, with the meeting concluding in a 9:3 vote in favor of the benefit-risk profile of patisiran.
The filing offers the first insight into how a group could benefit for helping the feds unravel the largest corruption scandal in Lansing in 30 years.
The scheme's alleged ringleader still awaits trial.
The scheme's alleged ringleader still awaits trial.
:quality(70)/cloudfront-us-east-1.images.arcpublishing.com/archetype/FWMU5ESZYBG2HLIZUEOMNULI7I.jpg)
The scheme's alleged ringleader still awaits trial.